Dec 4
|
Here's Why You Should Invest in Haemonetics (HAE) Right Now
|
Dec 4
|
Thermo Fisher (TMO) Advances Health Equity via New Partnership
|
Dec 4
|
BiomX (PHGE) Reports Positive Pulmonary Infection Treatment Data
|
Dec 1
|
HAE vs. SYK: Which Stock Should Value Investors Buy Now?
|
Dec 1
|
Neogen (NEOG) Unveils New Assay for Walnut Allergens Detection
|
Dec 1
|
CVS Health's (CVS) Digital Focus Aids Growth, Macro Issues Ail
|
Dec 1
|
Walgreens (WBA) Launches Rx Savings Finder Digital Tool
|
Nov 30
|
Thermo Fisher (TMO) Extends Partnership With Flagship Pioneering
|
Nov 30
|
Charles River (CRL) Gains on Price & Volume Growth Amid FX Woe
|
Nov 30
|
Inspira (IINN) Expands in Life Support Space With New Deal
|
Nov 30
|
Haemonetics (HAE) Loses -6.71% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
|
Nov 30
|
Penumbra (PEN) Enrolls First Patient in Landmark STORM-PE Trial
|
Nov 29
|
Here's Why You Should Retain Zimmer Biomet (ZBH) for Now
|
Nov 29
|
Quest Diagnostics' (DGX) New Pact to Scale Precision Medicine
|
Nov 29
|
Charles River (CRL) Backs the Quest to Cure SPG56 via New Deal
|
Nov 28
|
3 Reasons Why Growth Investors Shouldn't Overlook Haemonetics (HAE)
|
Nov 28
|
Smith & Nephew (SNN) New Buyout Expands Sports Medicine Suite
|
Nov 28
|
Penumbra's (PEN) Expansion Moves, New Launches Aid Growth
|
Nov 28
|
Bruker's (BRKR) New Collaboration to Use MALDI Biotyper System
|
Nov 28
|
Here's Why You Should Retain Teleflex (TFX) Stock for Now
|